Mati Therapeutics Inc. research brief
CIK 1574251
Generated Nov. 17, 2026, 8:13 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: AUSTIN Texas. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- July 2, 2026 · D/A · 0001574251-26-000001 · Source evidence
Reported offering amount: 4896500 USD. Reported amount sold: 2649815 USD.
- Oct. 8, 2025 · D · 0001574251-25-000003 · Source evidence
Reported offering amount: 10523695 USD. Reported amount sold: 9867695 USD.
- Sept. 23, 2025 · D · 0001574251-25-000002 · Source evidence
Reported offering amount: 2184175 USD. Reported amount sold: 2184175 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Mati Therapeutics Inc. research brief,” CIK 1574251, retrieved Nov. 17, 2026, 8:13 p.m.. Cite the specific accessions used. No amounts have been summed.